Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 164 active Myelodysplastic Syndrome trials
Revlimid in Transfusion Dependent Patients
Study Type: Interventional Phase 2
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
Study Type: Interventional Phase 1
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
Study Type: Interventional Phase 2
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
Study Type: Observational
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Study Type: Interventional Phase 1
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Study Type: Interventional Phase 2
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
Study Type: Interventional Phase 1
Inqovi Maintenance Therapy in Myeloid Neoplasms
Study Type: Interventional Phase 1
There are 164 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now